We’ve all heard the news about federal rescheduling of marijuana (finally), but now the American Medical Association is endorsing drug decriminalization as well. At its annual meeting held earlier in the year, the AMA formally endorsed drug decriminalization by adopting the policy position. AMA delegates voted 345-171 in favor of the decriminalization proposal. In addition, the organization is calling for the “elimination of criminal penalties for drug possession for personal use as part of a larger set of related public health and legal reforms designed to improve carefully selected outcomes.” A previous AMA board position recommended ongoing monitoring of effects on policy and public health, so this new endorsement is a stronger move. The American Society of Addiction Medicine, which has historically resisted reforms, last year spoke out about supporting drug decriminalization. The AMA has also advocated for psychedelics research, opposed the criminalization of kratom, and called for an end to the sentencing disparity between crack and powder cocaine. However, they also supported the continued inclusion of marijuana metabolites in employment-based drug tests.